Skip to main content
Premium Trial:

Request an Annual Quote

BforCure Gets CE Mark for 48-Well Flu/COVID Test Kit

NEW YORK – BforCure, a Paris-based point-of-care diagnostics firm, said on Monday it has received the CE-IVD mark for a PCR kit to detect influenza A, influenza B, and SARS-CoV-2.

The assay, called the Bfast [Flu A/Flu B/SARS-CoV-2] RT-PCR kit - 48, is intended for laboratories processing high volumes of samples and is provided in a 48-well microplate format. 

Last year, BforCure obtained the CE mark for its Chronos Dx portable qPCR thermocycler and also for a SARS-CoV-2 detection kit. The firm is developing multiple infectious disease panels for its point-of-care system. It also raised $2.3 million to adapt its platform for cancer detection.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.